By Lucy Tian | GAIA VF Intern
When given effective antiretroviral treatment (ARVs), newborn babies of HIV+ mothers avoid developing HIV. If given throughout pregnancy, the chances of the child being infected is near zero. When given to the newborn within their first three months of life, they are 3/4 less likely to die from an AIDS-related disease.
In 2019, a close investigation revealed that only 21 percent of pregnant women living with HIV in Mali received effective antiretrovirals for prevention of mother-to-child transmission of HIV. According to the UNICEF Data Warehouse, this is also a dramatic drop from previous years where 25 percent and higher of HIV+ mothers received effective antiretrovirals.
It is in this gap where GAIA Vaccine Foundation steps in. In 2020, despite the additional logistical barriers of the COVID-19 pandemic and a coup d'état, the Chez Rosalie Mother-to-Child-Transmission Prevention program treated 1,352 HIV+ women. Of their newborns, zero tested positive for HIV.
Support the incredible work of the Chez Rosalie program today!
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
